| Literature DB >> 20442623 |
Patricia Tueting1, John M Davis, Marin Veldic, Fabio Pibiri, Bashkim Kadriu, Alessandro Guidotti, Erminio Costa.
Abstract
Schizophrenia postmortem brain is characterized by gamma aminobutyric acid downregulation and by decreased dendritic spine density in frontal cortex. Protracted L-methionine treatment exacerbates schizophrenia symptoms, and our earlier work (Tremolizzo et al. and Dong et al.) has shown that L-methionine decreases reelin and GAD67 transcription in mice which is prevented by co-administration of valproate. In this study, we observed a decrease in spine density following L-methionine treatment, which was prevented by co-administration of valproate. Together with our earlier findings conducted under the same experimental conditions, we suggest that downregulation of spine density in L-methionine-treated mice may be because of the decreased expression of reelin and that valproate may prevent spine downregulation by inhibiting the methylation induced decrease in reelin.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20442623 PMCID: PMC2882068 DOI: 10.1097/WNR.0b013e3283373126
Source DB: PubMed Journal: Neuroreport ISSN: 0959-4965 Impact factor: 1.837